|
 | |
|
|
|
|
|
|
AHV Invests in Haven Behavioral Healthcare
8/27/2008 12:00:00 AM
(500
reads)
Nashville, Tennessee, June 2008 – Haven Behavioral Healthcare (“Haven”) a leading provider of specialty behavioral health services, announced that Ascension Health Ventures (“AHV”) has made an equity investment in the Company, joining existing investors Thoma Cressey Bravo, Clayton Associates and Haven management as shareholders. AHV is the general partner of CHV II, L.P., an investment fund formed by Ascension Health, Catholic Health Initiatives, Catholic Health East and Catholic Healthcare West.
Read More...
|
|
|
BioImagene Closes $26 M Series D Financing Round
8/27/2008 12:00:00 AM
(416
reads)
BioImagene, the leading provider of innovative digital pathology solutions for preclinical research and cancer diagnosis, today announced the closing of a $26 million series D financing round led by Burrill & Company. Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support.
Read More...
|
|
|
Catholic Healthcare West Joins CHV II, L.P.
3/18/2008 12:00:00 AM
(1516
reads)
Ascension Health announced today that Catholic Healthcare West (CHW) has become a limited partner in CHV II, LP, by acquiring a portion of Ascension Health’s commitment to this $200 million venture capital fund focused on making venture investments in the healthcare industry.
Read More...
|
|
|
Catholic Systems Partner to Form $200 Million Fund
10/5/2007 12:00:00 AM
(2158
reads)
Ascension Health, Catholic Health Initiatives and Catholic Health East have formed a $200 million venture capital fund. This limited partnership, CHV II, L.P., will invest in healthcare related companies. Ascension Health Ventures will act as general partner of the fund.
Read More...
|
|
|
AHV Closes Four New Investments
8/24/2007 12:00:00 AM
(1778
reads)
In its most prolific year since formation in 2001, Ascension Health Ventures (AHV) closed investments in four new portfolio companies. The new companies are in the device and service sectors and complement AHV’s diversified portfolio. Upon closing these investments, AHV’s $125 million fund is now fully invested, committed and reserved.
Read More...
|
|
|
AHV Invests in Impulse Monitoring
4/10/2007 12:00:00 AM
(1214
reads)
AHV has invested in a $4.5 million Series B financing of Impulse Monitoring, Inc., a company that provides intra-operative neurophysiological monitoring during invasive surgical procedures.
Read More...
|
|
|
AHV Invests in EKOS Corporation
3/31/2006 9:58:11 AM
(2101
reads)
AHV has invested in a $26 million Series C financing of EKOS Corporation, developer of an ultrasound assisted drug delivery platform.
Read More...
|
|
|
AHV Invests in Optiscan Biomedical
1/18/2006 12:43:22 PM
(3093
reads)
AHV recently invested in Optiscan Biomedical Corporation, developer of a highly accurate glucose monitoring device for use in the hospital ICU.
Read More...
|
|
|
AHV Invests in BodyMedia
9/16/2005 12:00:00 AM
(2390
reads)
AHV recently led a Series E financing in BodyMedia, Inc., a world leader in the design and development of wearable body monitoring products and services.
Read More...
|
|
|
AHV Invests in CHF Solutions
4/29/2005 12:00:00 AM
(1913
reads)
AHV has participated in a Series E financing of CHF Solutions, Inc.
Read More...
|
|
|
AHV Invests in Confluent Surgical
3/31/2005 12:00:00 AM
(1361
reads)
AHV has participated in a Series D financing of Confluent Surgical, Inc.
Read More...
|
|
|
AHV Makes Commitment to Sanderling Ventures
3/31/2005 12:00:00 AM
(603
reads)
AHV has committed to Sanderling Venture Partners Fund VI, L.P.
Read More...
|
|
|
|
|
|
|
|
|
|
|
|